Document is current
Any future updates will be listed below
-
Authors
Liu, Ling
He, Hao
Liang, Meihao
Beck, Jennifer https://orcid.org/0000-0002-5969-4647
Sinderby, Christer
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05378802 at ClinicalTrials.govDocuments that mention this clinical trial
Estimation of transpulmonary driving pressure using a lower assist maneuver (LAM) during synchronized ventilation in patients with acute respiratory failure: a physiological study
https://doi.org/10.1186/s40635-024-00674-z
-
Funding
Funding for this research was provided by:
Key Technologies Research and Development Program (2022YFC2504405)
National Natural Science Foundation of China (82341032, 82270083)
“333 Project” of Jiangsu Province (LGY2022025)
- License Information
-
More Information
Article History
Received: 22 April 2024
Accepted: 11 September 2024
First Online: 4 October 2024
Declarations
:
: The protocol was approved by Institutional Ethics Committee of Zhongda hospital (Approval Number: 2021ZDSYLL216-P01, September 1, 2021), and informed consent was obtained from the patients or next of kin. The trial “Predict Transpulmonary Pressure through ZAM”) was registered at clinicaltrials.gov (ID NCT05378802) on November 6, 2021. The procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975.
: Not applicable.
: JB and CS have made inventions related to neural control of mechanical ventilation that are patented. The patents are assigned to the academic institution(s) where inventions were made. The license for these patents belongs to Maquet Critical Care. Future commercial uses of this technology may provide financial benefit to JB and CS through royalties. JB and CS each own 50% of Neurovent Research Inc (NVR). NVR is a research and development company that builds the equipment and catheters for research studies. NVR has a consulting agreement with Maquet Critical Care. St-Michael’s Hospital has a research agreement with Maquet Critical Care AB (Solna, Sweden) and receives royalty and overhead from this agreement. The remaining authors have no competing interests to declare.
